Enovis (NYSE:ENOV) Director Sharon Wienbar Buys 924 Shares of Stock

Key Points

• Director Sharon Wienbar bought 924 Enovis shares at an average price of $26.98, spending about $24,930. The purchase increased her position by 2.16% to 43,777 shares.
• Enovis reported quarterly earnings of $0.88 per share, beating the $0.77 consensus estimate; revenue of $558.73 million also slightly exceeded expectations and rose 1.8% year over year.
• Analysts give Enovis a consensus “Moderate Buy” rating, with an average price target of $38.62; 10 analysts rate it Buy, one Hold, and one Sell.

Enovis Corporation (NYSE:ENOV - Get Free Report) Director Sharon Wienbar purchased 924 shares of the firm's stock in a transaction dated Monday, November 9th. The stock was purchased at an average cost of $26.98 per share, for a total transaction of $24,929.52. Following the acquisition, the director owned 43,777 shares of the company's stock, valued at approximately $1,181,103.46. This trade represents a 2.16% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Enovis Price Performance

NYSE:ENOV traded down $0.29 during trading hours on Tuesday, hitting $28.25. 1,596,570 shares of the company's stock traded hands, compared to its average volume of 1,879,434. The firm has a market cap of $1.63 billion, a P/E ratio of 8.44 and a beta of 1.31. Enovis Corporation has a 52 week low of $16.70 and a 52 week high of $32.41. The business's fifty day simple moving average is $20.05 and its two-hundred day simple moving average is $23.14. The company has a quick ratio of 1.08, a current ratio of 2.15 and a debt-to-equity ratio of 0.82.

Enovis (NYSE:ENOV - Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $0.88 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.11. The firm had revenue of $558.73 million for the quarter, compared to analysts' expectations of $557.12 million. Enovis had a positive return on equity of 13.23% and a negative net margin of 22.86%. The company's revenue was up 1.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.75 EPS. On average, research analysts anticipate that Enovis Corporation will post 3.15 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on ENOV shares. Zacks Research raised shares of Enovis from a "strong sell" rating to a "hold" rating in a report on Wednesday, July 29th. BMO Capital Markets set a $27.00 price objective on shares of Enovis in a report on Tuesday, September 1st. Wells Fargo & Company upped their target price on shares of Enovis from $33.00 to $37.00 and gave the stock an "overweight" rating in a research report on Friday. Wall Street Zen raised Enovis from a "hold" rating to a "buy" rating in a research note on Saturday, October 31st. Finally, Weiss Ratings upgraded Enovis from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Monday, November 2nd. Ten research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $38.62.

Hedge Funds Weigh In On Enovis

Institutional investors and hedge funds have recently made changes to their positions in the business. Public Sector Pension Investment Board lifted its stake in Enovis by 66.0% in the third quarter. Public Sector Pension Investment Board now owns 328,148 shares of the company's stock worth $6,223,000 after purchasing an additional 130,436 shares during the last quarter. Intech Investment Management LLC grew its stake in shares of Enovis by 477.1% during the third quarter. Intech Investment Management LLC now owns 70,796 shares of the company's stock valued at $1,293,000 after buying an additional 58,528 shares during the last quarter. Maryland State Retirement & Pension System bought a new position in shares of Enovis during the third quarter valued at about $238,000. Illinois Municipal Retirement Fund grew its stake in shares of Enovis by 22.4% during the third quarter. Illinois Municipal Retirement Fund now owns 38,366 shares of the company's stock valued at $701,000 after buying an additional 7,028 shares during the last quarter. Finally, Private Management Group Inc. increased its holdings in shares of Enovis by 31.3% in the third quarter. Private Management Group Inc. now owns 1,792,429 shares of the company's stock worth $32,748,000 after buying an additional 427,347 shares during the period. Institutional investors own 98.45% of the company's stock.

Enovis Company Profile

Enovis is a medical technology company that develops products and solutions for orthopedic care, surgery, recovery and rehabilitation. Its offerings include joint replacement implants, foot and ankle products, surgical instruments, orthopedic braces and supports, and rehabilitation equipment. The company serves healthcare providers and patients in markets around the world. Its products are designed to support treatment across different stages of musculoskeletal care, from surgical intervention to recovery and mobility.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.